Florence Anthony A. Jr.
SEC insider (Form 3/4/5 filer). CIK 0001559827. 10% Owner at Korro Bio, Inc. (KRRO) and 4 other issuers. 43 reported Form 4/5 transactions since Sep 2024; latest on Mar 10, 2026. Located in NEW YORK, NY.
Companies Florence Anthony A. Jr. has filed insider reports for
- Korro Bio, Inc. (KRRO): 10% Owner
- Trevi Therapeutics, Inc. (TRVI): 10% Owner
- SpyGlass Pharma, Inc. (SGP): 10% Owner
- NeueHealth, Inc. (NEUE): 10% Owner
- MBX Biosciences, Inc. (MBX): 10% Owner
Florence Anthony A. Jr.
CIK: 0001559827
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (43 total)
- Mar 10, 2026KRRO
Korro Bio, Inc.
PurchaseIndirect207.1K shares at avg. $11.11$2.3M - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
ConversionIndirect738K shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
ConversionIndirect1.4M shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
PurchaseIndirect937.5K shares at avg. $16.00$15.0M - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
ConversionIndirect402.3K shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
ConversionIndirect955K shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
ConversionIndirect1.6M shares- - Feb 9, 2026SGP
SpyGlass Pharma, Inc.
ConversionIndirect1.4M shares- - Oct 2, 2025NEUE
NeueHealth, Inc.
In-the-MoneyIndirect189.2K shares at avg. $0.01$2K - Oct 2, 2025NEUE
NeueHealth, Inc.
DispositionIndirect43.7K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 10, 2026 |  KRRO Korro Bio, Inc. | Purchase | 207,100 | $11.11 | $2,300,881 | Indirect |
| Feb 9, 2026 |  SGP SpyGlass Pharma, Inc. | Conversion | 737,962 | - | $0 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion | 1,370,168 | - | $0 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Purchase | 937,500 | $16.00 | $15,000,000 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion | 402,273 | - | $0 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion | 954,990 | - | $0 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion | 1,619,240 | - | $0 | Indirect |
| Feb 9, 2026 | SGP SpyGlass Pharma, Inc. | Conversion | 1,370,168 | - | $0 | Indirect |
| Oct 2, 2025 |  NEUE NeueHealth, Inc. | In-the-Money | 189,195 | $0.01 | $1,892 | Indirect |
| Oct 2, 2025 | NEUE NeueHealth, Inc. | Disposition | 43,678 | - | - | Indirect |
1-10 of 43 transactions